Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Japan by Year
Japan — Share of consolidated total revenues [legacy through FY23] (%) (%)
Pfizer Japan: 6.0% in FY2023, down 2.0 pts from a year earlier. No newer figure appears in the documents we track.
Latest, FY2023
6.0%
Period ended Dec 31, 2023
Change on a year earlier
-2.0 pts
8.0% in FY2022
History
7 years
Since FY2017
Sources
7
Documents cited below
Where the FY2023 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Note 17 — Significant Customers & Geographic Concentration.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Japan — Share of consolidated total revenues [legacy through FY23] (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | 6.0% | -2.0 pts | Form 10-K (filed 2026-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 8.0% | -1.0 pts | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 9.0% | +3.0 pts | Form 10-K (filed 2024-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 6.0% | 0.0 pts | Form 10-K (filed 2023-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 6.0% | +1.0 pts | Form 10-K (filed 2022-02-24) ↗ |
| FY2018 | Dec 31, 2018 | 5.0% | -3.0 pts | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 8.0% | – | Form 10-K (filed 2020-02-27) ↗ |
Cite this data
StockData. (2026). Pfizer Japan (%), annual FY2017–FY2023 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/conc-geo-jp-leg
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.